| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Collaboration revenues | ||||||
13,801 | 7,136 | 2,060 | ||||
Operating expenses: | ||||||
Research and development | ||||||
25,540 | 20,761 | 11,866 | ||||
General and administrative | ||||||
14,560 | 8,121 | 6,407 | ||||
Total operating expenses | ||||||
40,100 | 28,882 | 18,273 | ||||
Loss from operations | ||||||
-26,299 | -21,746 | -16,213 | ||||
Other income (expense): | ||||||
Interest and other income | ||||||
814 | 169 | 50 | ||||
Other expense, net | ||||||
-5,377 | -665 | -119 | ||||
Total other income (expense), net | ||||||
-4,563 | -496 | -69 | ||||
Net loss before income tax provision | ||||||
-30,862 | -22,242 | -16,282 | ||||
(Benefit from) provision for income taxes | ||||||
-254 | -396 | -23 | ||||
Net loss | ||||||
-30,608 | -21,846 | -16,259 | ||||
Net loss attributable to ordinary shareholders | ||||||
-30,608 | -21,846 | -16,259 | ||||
Net loss per share attributable to ordinary shareholders, basic and diluted | ||||||
-2.77 | -49.78 | -48.81 | ||||
Weighted average ordinary shares outstanding, basic and diluted | ||||||
11,045 | 438 | 333 | ||||
Comprehensives Loss: | ||||||
Net loss | ||||||
-30,608 | -21,846 | -16,259 | ||||
Other comprehensive income (loss): | ||||||
Foreign currency translation adjustment | ||||||
216 | -1,820 | 2,355 | ||||
Total comprehensive loss | ||||||
-30,392 | -23,666 | -13,904 | ||||